Trypanosoma cruzi: differences in cell surface interaction of circulating (trypomastigote) and culture (epimastigote) forms with macrophages.
Characteristics of the association of circulating (trypomastigote) and cultured (epimastigote) forms of Trypanosoma cruzi with macrophages were studied. Treatment of mouse macrophages with the anti-microfilament drug cytochalasin D severely reduced the ability of these cells to bind either trypomastigotes or epimastigotes. Instead, treatment with the antimicrotubule drug colchicine or 2-deoxyglucose afforded differential effects because epimastigote but not trypomastigote association with the macrophages was significantly inhibited. Prior treatment of epimastigotes with either trypsin or neuraminidase decreased their uptake by macrophages whereas treatment of trypomastigotes with either enzyme increased it. Pretreatment of macrophages with neuraminidase did not affect epimastigote uptake but reduced that of trypomastigotes. Pretreatment of macrophages with trypsin reduced the uptake of both forms of the parasite. However, quantitative differences in the extent of such reduction were noted when varying concentrations of trypsin were used, epimastigote uptake being more drastically affected. These results suggest that the initial interaction of virulent circulating trypomastigote and the attenuated cultured epimastigote forms of T. cruzi to macrophages may involve attachment via different surface structures.
D000818:Animals; D003078:Colchicine / Q000494:pharmacology; D003572:Cytochalasins / Q000494:pharmacology; D003847:Deoxyglucose / Q000494:pharmacology; D005260:Female; D008264:Macrophages / Q000469:parasitology*; D051379:Mice; D008813:Mice, Inbred ICR; D009439:Neuraminidase / Q000494:pharmacology; D012794:Sialic Acids / Q000502:physiology; D014349:Trypanosoma cruzi / Q000502:physiology*; D014357:Trypsin / Q000494:pharmacology
D003572:Cytochalasins; D012794:Sialic Acids; D003847:Deoxyglucose; D009439:Neuraminidase; D014357:Trypsin; D003078:Colchicine